TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

FROM DISCOVERY TO CURE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

FROM DISCOVERY TO CURE

ST13

US500000079115014

Classe

36, 41, 42, 44

Pedido

79115014

Registro

4366418

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

61

Atualização mais recente

12/02/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

36, 41, 42, 44

Data de depósito

05/01/2012

Data de registro

16/07/2013

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/05/2024

Última transação

12/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

01

Localização do titular

DE

Examinador

TWOHIG,SHANNON MARIE

Unidade examinadora

L50

Localização atual

GENERIC WEB UPDATE

Descrição da marca

The mark consists of a green four leaf clover outlined in black and white. To the right of the clover is the wording "FROM DISCOVERY TO CURE" in black.

Titulares e representantes

Titulares

P. K. (pessoa física)
P. S. (pessoa física)
P. S. (pessoa física)

Representantes

Patricia A. Walker Walker & Jocke Co., LPA

Classificação técnica

Classes Nice

Classe 36Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 36

Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans

Classe 41

Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and related medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children

Classe 42

Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children

Classe 44

Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling

Publicações

Histórico de despachos e eventos da marca no USPTO.

61 publicações encontradas

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/02/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/02/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

11/05/2024

71AG

REGISTERED-SEC.71 ACCEPTED

11/05/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

25/03/2024

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

30/10/2023

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

16/09/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/09/2023

ES71

TEAS SECTION 71 RECEIVED

14/07/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

18/11/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

16/07/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

20/01/2022

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

23/04/2021

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

23/04/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

20/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

20/02/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

20/02/2020

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

28/12/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/11/2019

ES75

TEAS SECTION 71 & 15 RECEIVED

03/10/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

27/12/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/06/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

13/03/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

25/02/2014

FIMP

FINAL DISPOSITION PROCESSED

25/02/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/10/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

16/07/2013

GPNX

NOTIFICATION PROCESSED BY IB

01/07/2013

PUBO

PUBLISHED FOR OPPOSITION

30/04/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2013

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2013

NPUB

NOTICE OF PUBLICATION

10/04/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/03/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/03/2013

CNEA

EXAMINERS AMENDMENT MAILED

18/03/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

15/03/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

15/03/2013

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

13/03/2013

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

10/03/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

25/02/2013

ALIE

ASSIGNED TO LIE

24/02/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/02/2013

CNEA

EXAMINERS AMENDMENT MAILED

12/02/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

12/02/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/02/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/02/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/02/2013

RFNT

REFUSAL PROCESSED BY IB

30/08/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/08/2012

RFRR

REFUSAL PROCESSED BY MPU

08/08/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/08/2012

CNRT

NON-FINAL ACTION WRITTEN

07/08/2012

MAFR

APPLICATION FILING RECEIPT MAILED

07/08/2012

DOCK

ASSIGNED TO EXAMINER

03/08/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/08/2012

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/08/2012

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace FROM DISCOVERY TO CURE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.